Astellas Pharma Gmbh

Sony Corporation

Takao Okuda

Fukushi Hirayama

Yuji Koga

Susumu Watanuki

Hiroyuki Moritomo

Jun Takasaki

Daisuke Kaga

Hiroshi Kawaguchi

Takashi Kamikubo

Atsushi Mitsuzawa

Issei Tsukamoto

Jiro Fujiyasu

Tatsuo Nagamatsu

Tsutomu Teranishi

Michihito Kageyama

Kunitoshi Shimizu

Toshio Uemura

Yumiko Moritani

Takashi Shibuya

Hideki Kubota

Masanori Miura

Masaki Abe

Keizo Sugasawa

Ippei Sato

Shunichiro Hachiya

Ken-Ichi Suzuki

Kazuyoshi Obitsu

Yoh Terada

Eisuke Nozawa

Ryo Mizoguchi

Kazuhiro Terai

Koichiro Harada

Mai Isomura

Tohru Ugawa

An information processing device includes a communication controller that performs communication control for receiving transmission data transmitted from a client, transmitting the transmission data to a first service providing server that performs a first service process, receiving a first service process result from the first service providing server, transmitting data according to the first service process result to a second service providing server that performs a second service process that is different from a first service, receiving a second service process result from the second service providing server, and transmitting the second service process result to the client. The first service process result is obtained by performing the first service process on the transmission data. The second service process result is obtained by performing the second service process on the data according to the first service process result.

Information processing device and information processing method

A compound which is useful as an active ingredient of a pharmaceutical composition, for example, a pharmaceutical composition for treating chronic renal failure and/or diabetic nephropathy is provided.

Amide compound

[Problem] To provide a compound that has an intestinal phosphate transporter (NPT-IIb) inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia. [Means for Solution] The present inventors conducted their studies on a compound that has an NPT-IIb inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia. As a result, they created an aminoalkyl-substituted N-thienylbenzamide derivative which has NPT-IIb inhibitory action, thereby completing the present invention. The aminoalkyl-substituted N-thienylbenzamide derivative of the present invention has an NPT-IIb inhibitory action and can be used as an agent for preventing and/or treating hyperphosphatemia.

Aminoalkyl-substituted N-thienylbenzamide derivative

Disclosed are quinolone derivatives characterized in that these have lower alkyl, cycloalkyl or the like at the 1-position; &#x2014;N(R)C(O)-lower alkylene-COR, lower alkylene-COR, lower alkenylene-COR, &#x2014;O-lower alkylene-COR, &#x2014;O-(lower alkylene which may be substituted with &#x2014;COR)-aryl or &#x2014;O-lower alkenylene-COR(wherein Ris H or lower alkyl) at the 3-position; halogen at the 6-position; and amino group substituted with a substituent group having a ring structure at the 7-position, respectively, or pharmaceutically acceptable salts thereof, has excellent P2Y12 inhibitory activity. The quinolone derivatives have excellent platelet aggregation inhibitory activity. A method of using the compounds is also disclosed.

Quinolone derivative or pharmaceutically acceptable salt thereof

An information processing apparatus includes a selecting unit for selecting extraction information concerning contents to be extracted from among a plurality of contents organized in time sequence, the extraction information prepared on a per content basis for the contents to be extracted and including a feature contained in the content to be extracted, and an extraction range that is represented with respect to the position of the feature, a detecting unit for detecting, from the contents, the same feature as the feature contained in the extraction information selected by the selecting unit, and an extracting unit for extracting a predetermined content in accordance with the extraction range contained in the extraction information selected by the selecting unit if the detecting unit detects the same feature as the feature contained in the extraction information.

Apparatus, method, and computer program for processing information

Provided are quinolone derivatives having a lower alkyl or cycloalkyl at the 1-position; &#x2014;N(R)C(O)-lower alkylene-COR, lower alkylene-COR, lower alkenylene-COR, &#x2014;O-lower alkylene-COR, &#x2014;O-(lower alkylene which may be substituted with &#x2014;COR)-aryl or &#x2014;O-lower alkenylene-COR(wherein Ris H or lower alkyl) at the 3-position; halogen at the 6-position; and amino group substituted with a substituent group having a ring structure at the 7-position, respectively, or pharmaceutically acceptable salts thereof. Pharmaceutical composition containing the quinolone derivatives and methods of using the compositions are provided.

A platelet aggregation inhibitor comprising a quinolone derivative or a pharmaceutically acceptable salt thereof as an active ingredient, and a novel quinolone derivative or a pharmaceutically acceptable salt thereof useful as a platelet aggregation inhibitor.

Quinolone derivative or salt thereof

An information processing apparatus includes a selector for selecting removal information concerning contents to be removed, the removal information prepared on a per content basis for the contents to be removed and including a value uniquely determined from data within a data range of whole or part of a content to be removed, a first range that is the data range, and a second range that is a removal range represented by the position of the first range, a detector for detecting a range at a predetermined position within the whole content, having the same range as the first range contained in the removal information selected by the selector and the same value as the value uniquely determined and contained in the removal information, and a remover for removing a predetermined content based on the second range contained in the removal information selected by the selector if the detector detects the range at the predetermined position.

2-Acylaminothiazole derivatives or salts thereof which have a platelet increasing activity based on an excellent human c-mpl-Ba/F3 cell growth function and a function of accelerating formation of megakaryocytic colonies and which are useful for treating thrombocytopenia are provided.

2-acylaminothiazole derivative or salt thereof

Growing community of inventors

Tokyo, Japan

Takao Okuda